Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.
Inter- and intraindividual variation in the pharmacokinetics of oral chlorambucil was investigated in patients with chronic lymphocytic leukaemia. Five patients were given in randomized order 15, 40, 60 and 70 mg chlorambucil p.o. and plasma was analyzed for chlorambucil and its cytotoxic metabolite phenyl acetic acid mustard. The area under the plasma concentration-time curve of chlorambucil varied two- to fourfold between patients at each dose level. The AUC of the metabolite was higher and showed twofold interindividual variation. The intraindividual dose-corrected AUCcs also varied twofold. No dose dependency of the dose corrected AUC was seen either for chlorambucil or the metabolite. Elimination of both compounds form plasma was rapid, with half-lives of 1.01 and 1.94, respectively.
Hartvig
P
P
Hospital Pharmacy, University Hospital, Uppsala, Sweden.
Simonsson
B
B
Oberg
G
G
Wallin
I
I
Ehrsson
H
H
D000284:Administration, Oral; D000368:Aged; D002699:Chlorambucil / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000097:blood; D011897:Random Allocation
D009588:Nitrogen Mustard Compounds; C008826:phenacid; D002699:Chlorambucil